Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Meta Reports First Quarter 2024 Results
-
Leafly to Announce First Quarter 2024 Financial Results on May 9, 2024
-
Sensei Biotherapeutics to Present Topline Clinical Data from the SNS-101 Phase I Dose Escalation Study at the 2024 ASCO Annual Meeting
-
Pulse Biosciences Schedules First Quarter 2024 Financial Results Conference Call for May 7, 2024
-
Spruce Power Adds Industry Veteran to Lead Asset Operations
-
HubSpot to Announce First Quarter 2024 Financial Results on May 8, 2024
-
Erasca Announces Three Presentations at the 2024 ASCO Annual Meeting
-
Airbnb to Announce First Quarter 2024 Results
-
Acadia Pharmaceuticals to Announce First Quarter Financial Results on May 8, 2024
-
Amtech Systems to Announce Second Quarter 2024 Financial Results on Wednesday, May 8, 2024
-
ESS Inc. Schedules First Quarter 2024 Financial Results Conference Call
-
Inter Parfums, Inc. Reports Record 2024 First Quarter Net Sales
-
CONMED Corporation Promotes Patrick Beyer to Chief Operating Officer
-
ClearPoint Neuro Announces Initiation of Limited Market Release for the SmartFrame OR™ Stereotactic System
-
Nasdaq Announces Mid-Month Open Short Interest Positions in Nasdaq Stocks as of Settlement Date April 15, 2024
-
FNCB Bancorp, Inc. Declares Second Quarter 2024 Dividend
-
Mama’s Creations Reports Fourth Quarter and Fiscal Year 2024 Financial Results
-
Ethan Allen Reports Fiscal 2024 Third Quarter Results Highlighted by Robust Balance Sheet, Strong Cash Dividends and Double-Digit Operating Margin; Lower Demand Reflects Post Pandemic Period
-
Sabra Health Care REIT, Inc. Announces First Quarter 2024 Earnings Release Date and Conference Call
-
Venus Concept Announces Loan Purchase and Completion of First Phase of Refinancing
-
Black Diamond Therapeutics Announces Presentations at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
-
Fossil Group, Inc. Announces Date for First Quarter 2024 Earnings Release and Conference Call
-
Cardlytics Announces Timing of Its First Quarter 2024 Earnings Release
-
Traeger Announces Reporting Date for First Quarter Fiscal 2024 Financial Results
-
Predictive Oncology Announces Abstract Accepted for Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
-
AerSale Announces Date for First Quarter 2024 Earnings Release Conference Call
-
Beyond Meat® to Report First Quarter 2024 Financial Results on May 8, 2024
-
23andMe to Present Preliminary Efficacy and Biomarker Data for 23ME-00610 at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
-
Appian To Announce First Quarter 2024 Financial Results on May 2
-
ZimVie to Report First Quarter Financial Results on May 8, 2024
-
Safe Bulkers, Inc. Sets Date for the First Quarter 2024 Results, Conference Call, and Webcast
-
QIAGEN expands tuberculosis portfolio with new NGS Panel to support real-time surveillance and combat antimicrobial resistance
-
NVE Schedules Conference Call on Fourth-Quarter and Fiscal Year Results
-
NextCure to Present Phase 1b Data of NC410 in Combination with Pembrolizumab at ASCO 2024
-
ACV to Report First Quarter 2024 Financial Results on May 8, 2024
-
Corcept Therapeutics to Announce First Quarter Financial Results, Provide Corporate Update and Host Conference Call
-
Avivagen Makes Voluntary Assignment into Bankruptcy Under the BIA
-
Amplify Energy Schedules First Quarter 2024 Earnings Release and Conference Call
-
CACI Reports Results for Its Fiscal 2024 Third Quarter and Raises Fiscal Year Guidance
-
BioMarin Reports Record Financial Results for the First Quarter 2024
-
CONMED Corporation Announces First Quarter 2024 Financial Results
-
Appulse Corporation - Reporting 2023 Results
-
Churchill Downs Incorporated Reports 2024 First Quarter Results
-
Finward Bancorp Announces Earnings for the Quarter Ended March 31, 2024
-
FibroGen Announces Clinical Data from Dose Escalation Phase 1b Study of FG-3246 (FOR46) in Combination with Enzalutamide in Patients with Metastatic Castration Resistant Prostate Cancer will be Prese
-
James Bay Resources Limited Announces Costs Award from Judgement Received in Claims Against Mak Mera and Wale Sola
-
Intra-Cellular Therapies Announces Closing of $575 Million Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
Great Lakes Announces New $150,000,000 Second-Lien Financing Agreement
-
Align Technology Announces First Quarter 2024 Financial Results
-
SEI Reports First-Quarter 2024 Financial Results

